Laurion Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Laurion Capital Management's DGX Position: Q4 2020 in Review
Laurion Capital Management sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 11,447 shares — an estimated $1.31M sold.
Laurion Capital Management first reported a position in DGX in Q3 2015 and held it in 11 quarters. The position peaked at $6.89M in Q3 2017. 811 funds tracked by Wall St. Rank hold DGX as of Q4 2020.
- Laurion Capital Management reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
- Laurion Capital Management sold 11,447 Quest Diagnostics shares in Q4 2020, an estimated $1.31M.
- Laurion Capital Management first reported a position in Quest Diagnostics in Q3 2015 and held it in 11 quarters.
- Laurion Capital Management's Quest Diagnostics position peaked at $6.89M in Q3 2017.
- 811 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.
Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.